What is Diabetes Type 2?

Diabetes type 2 is a condition in which the body is resistant to insulin resulting in high blood sugar levels. Symptoms include fatigue, hunger, thirst, increased urination, and tingling in feet and hands.

Treatment for diabetes type 2 includes medication, diet, and exercise. Common drug classes used to treat diabetes type 2 are biguanides, insulins, sulfonylureas, gliptins, glitazones, sulfonylurea / biguanide combinations, gliptin / biguanide combinations, GLP-1 agonists, ergot derivatives, glinides, glitazone / biguanide combinations, alpha glucosidase inhibitors, amlyn analogues, glitazone / sulfonylurea combinations, gliptin / statin combinations, gliptin / glitazone combinations, SGLT2 inhibitors, and glinide / biguanide combinations.

Savings Tips for Diabetes Type 2

  • 5 Common Medications That Can Kill

    July 13, 2015

    You probably already know that many prescriptions have side effects. Most are mild—annoying issues like nausea or sleepiness that are inconvenient at worst. Others, however, can be deadly.

    A very small number of medications are responsible for the majority of adverse side effects and hospitalizations from harmful drug reactions. How bad are these drugs? Between 2007 to 2009, almost 100,000 patients older than 65 had emergency hospitalizations for dangerous drug reactions, and almost 20,000 people die from prescription drug overdoses annually. See More

  • New Concentrated Humalog Pen Approved by the FDA

    June 18, 2015

    A new strength of Humalog has been approved by the FDA: the Humalog U-200 KwikPen will offer another form of rapid-acting insulin to improve sugar control in adults with type 1 and type 2 diabetes.

    What is rapid-acting insulin?

    Rapid-acting insulin lowers blood sugar levels quickly; once injected it can take effect within 15 minutes and can last anywhere from three to five hours, continuing to lower your blood sugar after a meal. See More

  • Ketoacidosis Warning Issued for New Diabetes Meds

    May 21, 2015

    On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.

    According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.

    Which medications are considered SGLT2 inhibitors?

    These medications also contain SGLT2 inhibitors in combination with other active ingredients:

    • Glyxambi (empagliflozin/linagliptin)
    • Invokamet (canagliflozin/metformin)
    • Xigduo XR (dapagliflozin/metformin)

    What should I do if I am taking one of these medications?

    If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More

see all savings tips

Popular Diabetes Type 2 Drugs

Popularity Drug Name Drug Class Price
Glucophage
(metformin)
Biguanides 5 See Prices
Lantus Insulins 387 See Prices
Glucophage XR
(metformin er)
Biguanides 6 See Prices
see all 96 drugs

Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Diabetes Type 2 Drug Classes

Copyright ©2015 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.